Cargando…
The rationale of using mesenchymal stem cells in patients with COVID‐19‐related acute respiratory distress syndrome: What to expect
The severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)‐caused coronavirus disease 2019 (COVID‐19) pandemic has become a global health crisis with an extremely rapid progress resulting in thousands of patients who may develop acute respiratory distress syndrome (ARDS) requiring intensive ca...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons, Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7404450/ https://www.ncbi.nlm.nih.gov/pubmed/32779878 http://dx.doi.org/10.1002/sctm.20-0164 |